Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Catalent Inc (NY: CTLT ) 56.37 +0.02 (+0.04%) Streaming Delayed Price Updated: 10:47 AM EDT, May 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Catalent Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > Why Erytech Pharma Are Shares Moving Higher Today April 25, 2022 Via Benzinga How To Attend Catalent Q3 2022 Earnings Conference Call April 21, 2022 Catalent (NYSE:CTLT) will host a conference call at 08:15 AM ET on May 3, 2022, to discuss Q3 2022 earnings results. How to Attend Catalent (CTLT) Conference Call Follow this link to access the live... Via Benzinga 24 Biggest Movers From Yesterday April 13, 2022 Gainers Vertical Aerospace Ltd. (NYSE: EVTL) Shares hiked 30.93% to close at $9.82 on Tuesday after Deutsche Bank initiated coverage of the stock. Peabody Energy Corporation (... Via Benzinga Markets Fall As Investors Weigh March CPI Report April 12, 2022 U.S. indices sold off to close Tuesday’s session following earlier strength. Investors reacted to the March CPI report and continue to assess Fed rate hike concerns. While... Via Benzinga The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout March 22, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Catalent's Q2 Earnings Beat Street View, Lifts FY22 Guidance February 01, 2022 Catalent Inc (NYSE: CTLT) has reported Q2 FY22 sales of $1. Via Benzinga Expert Ratings For Catalent January 27, 2022 Analysts have provided the following ratings for Catalent (NYSE:CTLT) within the last quarter: Via Benzinga Novo Nordisk Doubles 2025 Sales Target On Strong Wegovy Demand March 03, 2022 Novo Nordisk A/S (NYSE: NVO) has more than doubled its target for sales of obesity drugs by 2025 after overwhelming demand for its new Wegovy drug. Novo Nordisk aims to... Via Benzinga Executives Sell More Than $210M Of 5 Stocks February 09, 2022 Spanish stocks traded higher this morning, with the IBEX 35 Index surging to the strongest level in over two weeks. Investors, meanwhile, focused on some notable insider trades.... Via Benzinga The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program February 01, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga A Bearish Sign Appears On Catalent's Chart January 31, 2022 If history is any guide, there may be trouble ahead for shares of Catalent (NYSE:CTLT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... Via Benzinga The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News January 31, 2022 The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. Via Benzinga Expert Ratings For Catalent November 03, 2021 Analysts have provided the following ratings for Catalent (NYSE:CTLT) within ... Via Benzinga This Tattooed, Cowboy-Boot-Wearing Top CEO Refuses To Go Clean Cut January 20, 2022 John Chiminski knows he doesn't fit the traditional image of a corporate bigwig. And the Catalent CEO is not about to change. Via Investor's Business Daily FDA Concerns At Catalent Site Spurred Novo Nordisk's Wegovy Supply Woes: Report January 14, 2022 Last week, Catalent Inc (NYSE: CTLT) received an FDA write-up for its syringe filling facility in Belgium, "allegedly" the culprit behind supply shortage for... Via Benzinga A Look Into Catalent's Price Over Earnings December 30, 2021 In the current session, Catalent Inc. (NYSE:CTLT) is trading at $128.13, after a 0.1% increase. Over the past month, the stock increased by 0.34%, and in the past... Via Benzinga Catalent, inc (CTLT) Q1 2022 Earnings Call Transcript November 02, 2021 CTLT earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US November 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... Via Benzinga Exposures COVID-19 Where Catalent Stands With Analysts September 08, 2021 Analysts have provided the following ratings for Catalent (NYSE:CTLT) within ... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021 December 16, 2021 Upgrades According to B of A Securities, the prior rating for Generac Holdings Inc (NYSE: Via Benzinga The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga Chair And CEO Of Catalent Trades $22M In Company Stock October 06, 2021 John Chiminski, Chair And CEO at Catalent (NYSE:CTLT), made a large buy and sell of company shares on October 1, according to a new SEC filing. What Happened: A Form 4 filing from... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test September 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... Via Benzinga Market Rally At Highs, Led By Apple, Growth Stocks: Weekly Review September 03, 2021 The market rally hit fresh highs this week, with growth leading the way. Via Investor's Business Daily Topics Bonds Economy Stocks Exposures Debt Markets Fossil Fuels Interest Rates The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization September 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... Via Benzinga Exposures COVID-19 10 Biggest Price Target Changes For Tuesday August 31, 2021 Morgan Stanley raised Lowe's Companies, Inc. (NYSE:L... Via Benzinga The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod September 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... Via Benzinga Exposures Product Safety Catalent, inc (CTLT) Q4 2021 Earnings Call Transcript August 30, 2021 CTLT earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself September 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... Via Benzinga The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab September 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... Via Benzinga Exposures COVID-19 Product Safety < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
